Abiopharma

New Form SCHEDULE 13G/A - Mirum Pharmaceuticals, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000128 Size: 10 KB

New Form SCHEDULE 13G/A - AVADEL PHARMACEUTICALS PLC Filed: 2025-05-14 AccNo: 0001274173-25-000129 Size: 10 KB

Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

New Form SCHEDULE 13G/A - Ascendis Pharma A/S Filed: 2025-05-14 AccNo: 0001274173-25-000126 Size: 9 KB

New Form SCHEDULE 13G/A - Monopar Therapeutics Filed: 2025-05-14 AccNo: 0001274173-25-000127 Size: 10 KB

New Form SCHEDULE 13G - Travere Therapeutics, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000125 Size: 9 KB

New Form SCHEDULE 13G - Tyra Biosciences, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000122 Size: 9 KB

New Form SCHEDULE 13G - Verona Pharma plc Filed: 2025-05-14 AccNo: 0001274173-25-000120 Size: 9 KB

New Form SCHEDULE 13G - Praxis Precision Medicines, Inc. Filed: 2025-05-14 AccNo: 0001274173-25-000119 Size: 9 KB

NRC Health & TGI | Shaping the Future of Healthcare Together in Orlando

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

New SEC Filing for Avanos Medical Inc. (NYSE:AVNS)

New Form 4 - RETRACTABLE TECHNOLOGIES INC Filed: 2025-05-14 AccNo: 0001415889-25-012853 Size: 7 KB

New Form 4 - ICU MEDICAL INC/DE Filed: 2025-05-14 AccNo: 0000950170-25-071019 Size: 8 KB

Community Health Systems to Participate in 2025 RBC Capital Markets Global Healthcare Conference